Cite

HARVARD Citation

    Norman, S. et al. (n.d.). 562. Tocilizumab for the Treatment of Severe COVID-19: A Retrospective, Multi-Center, Case-Matched Series. Open forum infectious diseases. p. S346. [Online]. 
  
Back to record